Hayato Iwase1, Burcin Ekser1,2, Huidong Zhou1,3, Hong Liu4, Vikas Satyananda1, Rishab Humar1, Pooja Humar1, Hidetaka Hara1, Cassandra Long1, Jay K Bhama5, Pietro Bajona1, Yi Wang3, Martin Wijkstrom1, David Ayares6, Mohamed B Ezzelarab1, David K C Cooper1. 1. Thomas E Starzl Transplantation Institute, University of Pittsburgh, Pittsburgh, PA, USA. 2. Department of Surgery Transplantation and Advanced Technologies, Vascular Surgery and Organ Transplant Unit, University Hospital of Catania, Catania, Italy. 3. Center for Kidney Transplantation, Second Affiliated Hospital of the University of South China, Hengyang, Hunan, China. 4. Department of General Surgery, First Hospital of Shanxi Medical University, Taiyuan, China. 5. Department of Cardiac Surgery, University of Pittsburgh, Pittsburgh, PA, USA. 6. Revivicor, Blacksburg, VA, USA.
Abstract
INTRODUCTION: In pig-to-baboon heart/artery patch transplantation models, adequate costimulation blockade prevents a T-cell response. After heart transplantation, coagulation dysfunction (thrombocytopenia, reduced fibrinogen, increased D-dimer) and inflammation (increased C-reactive protein [CRP]) develop. We evaluated whether coagulation dysfunction and/or inflammation can be detected following pig artery patch transplantation. METHODS: Baboons received heart (n = 8) or artery patch (n = 16) transplants from genetically engineered pigs and a costimulation blockade-based regimen. Heart grafts functioned for 15-130 days. Artery recipients were euthanized after 28-84 days. Platelet counts, fibrinogen, D-dimer, and CRP were measured. RESULTS: Thrombocytopenia and reduced fibrinogen developed only in recipients of hearts not expressing a coagulation-regulatory protein (n = 4), but not in other heart or patch recipients. However, in heart recipients (n = 8), there were sustained increases in D-dimer (<0.5 to 1.9 ug/ml [P < 0.01]) and CRP (0.26-2.2 mg/dl [P < 0.01]). In recipients of artery patches, there were also sustained increases in D-dimer (<0.5 to 1.4 ug/ml [P < 0.01]) and CRP (0.26 to 1.5 mg/dl [P < 0.001]). An IL-6R antagonist suppressed the increase in CRP, but not D-dimer. CONCLUSION: The pig artery patch model has proved valuable for determining immunosuppressive regimens that prevent sensitization to pig antigens. This model also provides information on the sustained systemic inflammation in xenograft recipients (SIXR). An IL-6R antagonist may help suppress this response.
INTRODUCTION: In pig-to-baboon heart/artery patch transplantation models, adequate costimulation blockade prevents a T-cell response. After heart transplantation, coagulation dysfunction (thrombocytopenia, reduced fibrinogen, increased D-dimer) and inflammation (increased C-reactive protein [CRP]) develop. We evaluated whether coagulation dysfunction and/or inflammation can be detected following pig artery patch transplantation. METHODS:Baboons received heart (n = 8) or artery patch (n = 16) transplants from genetically engineered pigs and a costimulation blockade-based regimen. Heart grafts functioned for 15-130 days. Artery recipients were euthanized after 28-84 days. Platelet counts, fibrinogen, D-dimer, and CRP were measured. RESULTS:Thrombocytopenia and reduced fibrinogen developed only in recipients of hearts not expressing a coagulation-regulatory protein (n = 4), but not in other heart or patch recipients. However, in heart recipients (n = 8), there were sustained increases in D-dimer (<0.5 to 1.9 ug/ml [P < 0.01]) and CRP (0.26-2.2 mg/dl [P < 0.01]). In recipients of artery patches, there were also sustained increases in D-dimer (<0.5 to 1.4 ug/ml [P < 0.01]) and CRP (0.26 to 1.5 mg/dl [P < 0.001]). An IL-6R antagonist suppressed the increase in CRP, but not D-dimer. CONCLUSION: The pig artery patch model has proved valuable for determining immunosuppressive regimens that prevent sensitization to pig antigens. This model also provides information on the sustained systemic inflammation in xenograft recipients (SIXR). An IL-6R antagonist may help suppress this response.
Authors: P J Cowan; A Aminian; H Barlow; A A Brown; C G Chen; N Fisicaro; D M Francis; D J Goodman; W Han; M Kurek; M B Nottle; M J Pearse; E Salvaris; T A Shinkel; G V Stainsby; A B Stewart; A J d'Apice Journal: Transplantation Date: 2000-06-27 Impact factor: 4.939
Authors: Paul M Ridker; Christopher P Cannon; David Morrow; Nader Rifai; Lynda M Rose; Carolyn H McCabe; Marc A Pfeffer; Eugene Braunwald Journal: N Engl J Med Date: 2005-01-06 Impact factor: 91.245
Authors: L Bühler; M Basker; I P Alwayn; C Goepfert; H Kitamura; T Kawai; S Gojo; T Kozlowski; F L Ierino; M Awwad; D H Sachs; R Sackstein; S C Robson; D K Cooper Journal: Transplantation Date: 2000-11-15 Impact factor: 4.939
Authors: Bruce E Loveland; Julie Milland; Peter Kyriakou; Bruce R Thorley; Dale Christiansen; Marc B Lanteri; Mark Regensburg; Maureen Duffield; Andrew J French; Lindsay Williams; Louise Baker; Malcolm R Brandon; Pei-Xiang Xing; Del Kahn; Ian F C McKenzie Journal: Xenotransplantation Date: 2004-03 Impact factor: 3.907
Authors: Stuart L Houser; Kenji Kuwaki; Christoph Knosalla; Frank J M F Dor; Bernd Gollackner; Jane Cheng; Akira Shimizu; Henk-Jan Schuurman; David K C Cooper Journal: Xenotransplantation Date: 2004-09 Impact factor: 3.907
Authors: Tao Li; Whayoung Lee; Hidetaka Hara; Cassandra Long; Mohamed Ezzelarab; David Ayares; Hai Huang; Yi Wang; Charles T Esmon; David K C Cooper; Hayato Iwase Journal: Transplantation Date: 2017-10 Impact factor: 4.939
Authors: Takayuki Yamamoto; Qi Li; Hidetaka Hara; Liaoran Wang; Hongmin Zhou; Juan Li; Devin E Eckhoff; A Joseph Tector; Edwin C Klein; Ray Lovingood; Mohamed Ezzelarab; David Ayares; Yi Wang; David K C Cooper; Hayato Iwase Journal: Transpl Immunol Date: 2018-08-06 Impact factor: 1.708
Authors: Hayato Iwase; Hong Liu; Tao Li; Zhongquiang Zhang; Bingsi Gao; Hidetaka Hara; Martin Wijkstrom; Cassandra Long; Ryan Saari; David Ayares; David K C Cooper; Mohamed B Ezzelarab Journal: Xenotransplantation Date: 2017-03-12 Impact factor: 3.907
Authors: Hayato Iwase; Hidetaka Hara; Mohamed Ezzelarab; Tao Li; Zhongqiang Zhang; Bingsi Gao; Hong Liu; Cassandra Long; Yi Wang; Amy Cassano; Edwin Klein; Carol Phelps; David Ayares; Abhinav Humar; Martin Wijkstrom; David K C Cooper Journal: Xenotransplantation Date: 2017-03-17 Impact factor: 3.907
Authors: Hayato Iwase; Burcin Ekser; Hidetaka Hara; Mohamed B Ezzelarab; Cassandra Long; Angus W Thomson; David Ayares; David K C Cooper Journal: Xenotransplantation Date: 2016-07-04 Impact factor: 3.907
Authors: Hidetaka Hara; Hayato Iwase; Huy Nguyen; Yuko Miyagawa; Kasinath Kuravi; Jeremy B Foote; Will Eyestone; Carol Phelps; David Ayares; David K C Cooper Journal: Cytokine Date: 2021-06-04 Impact factor: 3.861